Share
Print-Friendly PDF Print this page

RIVKA JUNGREIS

ASSOCIATE

  • J.D., 2008
    Brooklyn Law School
  • M.S., 2004
    Biology
    New York University
  • B.S., 2000
    Interdisciplinary Sciences
    Touro College
    (magna cum laude)
Rivka Jungreis
The New York Times Building
620 Eighth Avenue
New York, NY 10018
USA
212.459.7196

Rivka Jungreis is an associate in the firm’s Litigation Department and a member of its Intellectual Property Group. She joined Goodwin Procter in 2008.

WORK FOR CLIENTS

Ms. Jungreis has experience in intellectual property litigation in federal district courts and Federal Circuit patent appeals. She focuses her practice on pharmaceutical patent litigation.

Representative current matters include:
  • Teva Neuroscience, Inc. et al. v. Watson Pharma, Inc., et al., No. 10-5078 (CCC) (JAD) (D.N.J.): Representing Teva in patent litigation concerning Azilect®, Teva’s branded treatment for idiopathic Parkinson’s disease.  Teva filed suit under the Hatch-Waxman Act in 2010 and 2011 against four pharmaceutical companies seeking to market generic versions of Teva’s product.  The case is currently pending in the District of New Jersey.
  • ViiV Healthcare UK Ltd., et al. v. Teva Pharms. USA, Inc., No. 11-688 (RGA) (D. Del.): Representing Teva in a patent infringement litigation filed by ViiV under the Hatch-Waxman Act in response to Teva’s filing of an Abbreviated New Drug Application seeking approval to market a generic version of EPZICOM®, an abacavir/lamivudine tablet indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. This case is pending in the District of Delaware.

MEDIA

Ms. Jungreis is the co-author of several peer-reviewed scientific publications, which have appeared in the Journal of Clinical Investigation (2001), Molecular Cell (2001), The EMBO Journal (2003), Genes & Development (2004) and Cell Metabolism (2008).

PROFESSIONAL EXPERIENCE

Ms. Jungreis’ technical background includes five years of laboratory research experience in the department of molecular pathogenesis at New York University School of Medicine.

During law school, Ms. Jungreis served as a judicial intern to the Honorable Carol B. Amon, U.S. District Court for the Eastern District of New York. In addition, she worked as a legal intern in the patent department of OSI Pharmaceuticals, Inc., and in the trademark department of Colgate-Palmolive Company.

BAR AND COURT ADMISSIONS

Ms. Jungreis is admitted to practice in New York and New Jersey, and before the Southern and Eastern Districts of New York. She is a registered patent attorney admitted to practice before the U.S. Patent and Trademark Office.

RECOGNITION

While attending law school, Ms. Jungreis was a senior articles editor for the Journal of Law and Policy.